1044.HK
Hengan’s profit jumps on lower pulp prices

The Latest: Paper products maker Hengan International Group Co. Ltd. (1044.HK) on Thursday reported its revenue rose 5.1% to 23.8 billion yuan ($3.29 billion) last year, while its profit rose nearly 46% to 2.8 billion yuan.

Looking Up: The company lowered production costs last year after clearing out  inventory and capitalizing on wood pulp prices that began to ease in the second quarter.

Take Note: Hengan recorded a foreign exchange loss of about 150 million yuan for the year, marking a significant improvement from a 900 million yuan foreign exchange loss in 2022.

Digging Deeper: Hengan was founded in 1985 as a maker of paper products like sanitary napkins and tissue paper and has been publicly traded since 1998. The biggest factor affecting its costs is wood pulp prices, which are currently at a mid- to high level, without any clear indication of where they are heading, said CEO Hui Ching Lau. The company doesn’t anticipate any major changes in pulp prices in the short term and expects its revenue will remain stable this year.

Market Reaction: Hengan’s stock opened lower on Friday and closed down 4.8% at HK$24.75 by the midday break. The stock now trades at the middle to lower end of its 52-week range.

The Bamboo Works offers a wide-ranging mix of coverage on U.S.- and Hong Kong-listed Chinese companies, including some sponsored content. For additional queries, including questions on individual articles, please contact us by clicking here

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

Illustration of Luckin and Costa coffee being tasted

Luckin Coffee eyes global leap as China’s Double 11 loses its luster

Luckin could be preparing a bid for Costa Coffee. What's driving this potential deal, and what are its chances for success? And this year's Double 11 festival looks like a dud, with most big e-commerce companies failing to publish any big numbers. What does the future hold for this fast-fading shopping fest?
So-Young runs cosmetic surgery clinics

Can So-Young find new youth in bricks and mortar?

The cosmetic surgery specialist’s top line is growing as it opens new ‘light medical aesthetic’ clinics, but its bottom line is sagging as its older platform business evaporates Key Takeaways:…
CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

The pharmaceutical giant is paying the price for its aggressively low bids in China’s centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: The…